This is a $248,971.98 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of Luminex Beads, with no set-aside designation. Luminex is a prime contractor that provides specialized multiplex diagnostic platforms, assays, reagents, and services to federal agencies including the CDC, VA, DHA,...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention awarded a Purchase Order to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies, for MAGPLEX-C MICROSPHERES. The firm fixed-price contract has a potential value of $146,376.08 and will be performed in Atlanta, GA. The contract does not have a set-aside designation. Luminex Corp is known for providing proprietary testing platforms, assay kits, reagents, software, and...
This is a $20,791.54 firm-fixed price purchase order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of MICROSPHERE, MAGPLEXAVIDIN, REG 026, 1ML to the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract has a completion date of September 30, 2024 and was awarded on September 12, 2024. There is no set-aside designation for this award. Luminex has provided various diagnostic testing...
This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
This is a firm fixed-price purchase order issued by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies. The contract, valued at $95,567.12, is for the procurement of Luminex Microspheres. Luminex often serves as a prime contractor for the CDC, Department of Veterans Affairs, Department of Defense, and other federal agencies, providing specialized multiplexing systems and diagnostic testing products. While this award does...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies and diagnostic solutions, for LUMINEX 200 SERVICE. The $23,850.00 contract has a ceiling value and an ultimate completion date of July 7, 2027. This award does not utilize a set-aside mechanism. Luminex Corp, a foreign-owned, for-profit manufacturer, has provided specialized multiplexing systems, assay kits, reagents, and...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $148,550.00 firm fixed price purchase order to Luminex Corporation, a for-profit foreign-owned manufacturer, for a Gastrointestinal Pathogen Panel. This competitive contract does not utilize a set-aside. Luminex provides proprietary multiplexing technologies, diagnostic assays, and related products to support clinical testing and biomedical research efforts across various federal agencies including...